Characterization of dequalinium as a XIAP antagonist that targets the BIR2 domain

Author: Orzáez Mar  

Publisher: Springer Publishing Company

ISSN: 1360-8185

Source: Apoptosis, Vol.16, Iss.5, 2011-05, pp. : 460-467

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content